See also this year's filing and all EDGAR filings for this company.
PDF Report 0001356576_2023_SUPERNUS_PHARMACEUTICALS_INC.pdf
Logs
| info | Added remainder_ComprehensiveNetIncome directly from 10K | industry.us_generic | {} |
Graph
Absolute values for 0001356576, SUPERNUS PHARMACEUTICALS INC.
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 734,151,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 819,482,000 |
| 2 | PropertyPlantAndEquipmentNet | 0 |
| 3 | remainder_Assets | 148,875,000 |
| 4 | LiabilitiesCurrent | 687,958,000 |
| 5 | LiabilitiesNoncurrent | 44,690,000 |
| 6 | remainder_Liabilities | 83,656,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 377,221,000 |
| 9 | ResearchAndDevelopmentExpense | 74,552,000 |
| 10 | remainder_Expenses | 169,373,000 |
| 11 | remainder_Revenues | 667,238,000 |
| 12 | remainder_NetIncome | 14,619,000 |
| 13 | remainder_ComprehensiveNetIncome | -4,749,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 1,702,508,000 |
| 1 | Liabilities | 816,304,000 |
| 2 | Expenses | 621,146,000 |
| 3 | Revenues | 667,238,000 |
| 4 | StockholdersEquity | 886,204,000 |
| 5 | NetIncome | 60,711,000 |
| 6 | ComprehensiveNetIncome | 58,336,500 |
| 7 | BaseVar | 1,913,282,000 |
| 8 | EconomicCapitalRatio | 1.26 |
Edgar->Model Mapping
Feature Distribution
Change over Time
